Key result
Inappropriate enoxaparin for a misdiagnosed catheter sheath triggers severe retroperitoneal hematoma and shock.
Why the study?
Differentiating between pericatheter fibrous sheath and catheter-related thrombosis is critical to avoid inappropriate anticoagulation in cancer patients with central venous catheters.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case highlights the importance of accurately distinguishing pericatheter fibrous sheaths from thrombosis using echocardiography to avoid severe bleeding complications from inappropriate anticoagulation, particularly in high-risk oncology patients.
Case Presentation We report the case of a 63–year–old female with diagnosis of uterine leiomyosarcoma. Following total hysteroannessectomy, she commenced chemotherapy using a port–a–cath. A transthoracic echocardiogram revealed a 2 cm hyperechoic mass protruding into the right atrium. This finding was confirmed by transesophageal echocardiography, which identified the mass originating from the tip of the intravascular device. While D–dimer levels were mildly elevated, consistent with her neoplastic condition, and electrocardiogram and echocardiogram showed no overt signs of pulmonary embolism, a pulmonary angio–CT scan was performed, effectively ruling out pulmonary thromboembolism. The patient was subsequently started on anticoagulation with enoxaparin for a presumptive diagnosis of catheter–related thrombosis. However, during low–molecular–weight heparin therapy, she developed a retroperitoneal hematoma complicated by hemorrhagic shock, necessitating embolization of the inferior epigastric artery, the source of bleeding. The port–a–cath was removed during her hospitalization. Subsequent pathological examination of the catheter revealed the hyperechoic formation to be a fibrous sheath. Discussion This case underscores a critical diagnostic challenge in managing pericatheter vascular hyperechoic formations. A fibrous sheath is an inevitable consequence of central venous catheter implantation. In asymptomatic patients, a pericatheter hyperechoic structure is approximately five times more likely to be a fibrous sheath than a catheter–related thrombosis. While pericatheter thrombosis can be asymptomatic, it often correlates with vessel wall adherence, ultrasound compressibility, higher echogenicity, a greater thickness–to–length ratio, and demonstrable color doppler flow defects. Given these distinguishing features, color doppler ultrasound offers superior sensitivity and specificity for differentiating between these entities compared to computed tomography. Conclusion This case powerfully illustrates the urgent need for prompt differential diagnosis between a fibrous sheath and catheter–related thrombosis. Especially in oncological patients, who are at high risk for both thrombotic and hemorrhagic complications, an accurate diagnosis is paramount to avoid exposing them to potentially inappropriate anticoagulation therapies that could lead to severe adverse events.
No takes yet. Share an insight, caveat, or question.
Mauriello et al. (2026) conducted a case report in Uterine leiomyosarcoma with a pericatheter fibrous sheath (n=1). Enoxaparin was evaluated on Adverse events from anticoagulation therapy. Inappropriate administration of enoxaparin for a misdiagnosed pericatheter fibrous sheath in an oncology patient resulted in a retroperitoneal hematoma complicated by hemorrhagic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: